Xl. Han et al., INDUCTION OF A DNA ADDUCT DETECTABLE BY P-32 POSTLABELING IN THE DORSOLATERAL PROSTATE OF NBL CR RATS TREATED WITH ESTRADIOL-17-BETA AND TESTOSTERONE/, Carcinogenesis, 16(4), 1995, pp. 951-954
Treatment with estradiol-17 beta and testosterone induces epithelial d
ysplasia and, subsequently, adenocarcinoma in the dorsolateral prostat
e of NBL rats. The purpose of this study was to determine whether this
carcinogenic effect is mediated by genotoxicity. Analogous to adducts
produced by estrogens in the male hamster kidney, a target of estroge
n carcinogenicity, induction of DNA adducts detectable by P-32-postlab
eling was investigated in the prostate target tissue. NBL rats were tr
eated with separate Silastic tubing implants containing testosterone a
nd estradiol-17 beta. Control animals received empty implants, Animals
were killed at 8, 16 and 24 weeks after initiation of treatment, and
accessory sex glands were sampled for adduct analysis, DNA of the dors
olateral and ventral prostate and the coagulating gland (= anterior pr
ostate) was isolated and analyzed by nuclease P1-enhancement of the P-
32-post-labeling assay. DNA adducts were quantitated by Cerenkov count
ing, An adduct occurred selectively in DNA of the dorsolateral prostat
e of rats treated with estradiol plus testosterone for 16 or 24 weeks
with relative adduct level values of similar to 10x10(9), but not in D
NA of the ventral or anterior prostate. The adduct was not present in
DNA of prostate tissue of rats treated for 8 weeks or in DNA of contro
l tissues. This adduct was unique with respect to chromatographic loca
tion and has not been observed before in any tissue of control or horm
one-treated animals. Neither the structure of the treatment-induced ad
duct nor the mechanism of its formation is known. However, the selecti
ve occurrence of this adduct in the tissue of origin of the carcinomas
and its appearance coinciding with putative preneoplastic lesions and
preceding carcinoma development suggests a causal relation between ad
duct formation and prostate cancer development in testosterone plus es
tradiol-17 beta-treated rats.